Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Raises $20.6M in Stock Placement

NEW YORK, March 29 (GenomeWeb News) - MorphoSys has raised around17.1 million ($20.6 million) after placing 384,338 shares with international institutional investors, the company said today.


MorphoSys priced the shares at44.50 apiece. The issue was several times over-subscribed, the company said.


The company said the proceeds will enable it to raise its cash balance to approximately60 million. Additionally, the funding "allows us the flexibility to further expand the research antibody side of our business," CFO Dave Lemus said in a statement.


WestLB AG acted as lead manager of the transaction with DZ BANK as co-lead manager.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.